Financhill
Buy
51

NUE Quote, Financials, Valuation and Earnings

Last price:
$121.87
Seasonality move :
-0.98%
Day range:
$121.04 - $124.00
52-week range:
$97.59 - $170.52
Dividend yield:
1.78%
P/E ratio:
21.77x
P/S ratio:
0.95x
P/B ratio:
1.41x
Volume:
4.9M
Avg. volume:
2.4M
1-year change:
-26.67%
Market cap:
$28.2B
Revenue:
$30.7B
EPS (TTM):
$5.62

NUE Analysts' Consensus Rating

The 10 analysts providing 12-month price projections for Nucor shares anticipate an average target of $145.37, ranging from a low estimate of $120.00 to a high estimate of $175.00. This average target implies a growth of 18.85% compared to the current stock price of $122.32.

Consensus Price Target

$145.37

Highest Price Target

$175.00

Lowest Price Target

$120.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 4 5 5

Hold 7 6 5

Sell 0 0 0
Consensus Hold Hold Leans Bullish

NUE Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is It Time to Sell MercadoLibre?
Is It Time to Sell MercadoLibre?

MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…

Is Tesla Stock High Risk or High Reward?
Is Tesla Stock High Risk or High Reward?

EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…

Why Did Chase Coleman Buy TSM?
Why Did Chase Coleman Buy TSM?

Billionaire Chase Coleman of Tiger Global Management has built a…

Stock Ideas

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 48x

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
55
CTRN alert for Jun 4

Citi Trends [CTRN] is up 2.77% over the past day.

Sell
44
RGC alert for Jun 4

Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.

Buy
63
MLTX alert for Jun 4

MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock